How Did Biotech and Healthcare Stocks Perform During This 2 Day Trading Rally?…Update-1 earnings deliver!

Update-1 4/25...MRK up over 3% on confirmed guidance Revs at $63-64B,EPS $8.53-8.65, Junuvia drug on Medicare IRA targeted list, gains on blockbuster Keytruda Q1 sales of $6.9B. Anxious mood from META earnings, inflation and weak GDP scare investors but recovers.  AH risk appetite absorbed with...

Pin It on Pinterest